Background: Pheochromocytomas (PHEO) are tumors arising from chromaffin cells from the adrenal medulla, having the ability to produce, metabolize and secrete catecholamines. The overproduction of catecholamines leads by many mechanisms to the impairment in the left ventricle (LV) function, however, endocardial measurement of systolic function did not find any differences between patients with PHEO and essential hypertension (EH). The aim of the study was to investigate whether global longitudinal strain (GLS) derived from speckle-tracking echocardiography can detect catecholamine-induced subclinical impairments in systolic function. Methods: We analyzed 17 patients (10 females and seven males) with PHEO and 18 patients (nine females and nine males) with EH. The groups did not differ in age or in 24-h blood pressure values. Results: The patients with PHEO did not differ in echocardiographic parameters including LV ejection fraction compared to the EH patients (0.69 ± 0.04 vs. 0.71 ± 0.05; NS), nevertheless, in spackle-tracking analysis, the patients with PHEO displayed significantly lower GLS than the EH patients (-14.8 ± 1.5 vs. -17.8 ± 1.7; p < 0.001). Conclusions: Patients with PHEO have a lower magnitude of GLS than the patients with EH, suggesting that catecholamines induce a subclinical decline in LV systolic function.

3rd Department of Medicine Centre for Hypertension General University Hospital and 1st Faculty of Medicine Charles University Prague Ovocný trh 5 116 36 Prague 1 Czech Republic

Department of Nephrology General University Hospital and 1st Faculty of Medicine Charles University Prague Ovocný trh 5 116 36 Prague 1 Czech Republic

Zobrazit více v PubMed

Pacak K., Keiser H.R., Eisenhofer G. Pheochromocytoma. In: DeGroot L.J., Jamenson J.L., editors. Endocrinology. 5th ed. Elsevier Saunders; Philadelphia, PA, USA: 2006. pp. 2501–2534.

Ariton M., Juan C.S., AvRuskin T.W. Pheochromocytoma: Clinical observations from a Brooklyn tertiary hospital. Endocr. Pract. 2000;6:249–252. doi: 10.4158/EP.6.3.249. PubMed DOI

Omura M., Saito J., Yamaguchi K., Kakuta Y., Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens. Res. 2004;27:193–202. PubMed

Lenders J.W., Eisenhofer G., Mannelli M., Pacak K. Phaeochromocytoma. Lancet. 2005;366:665–675. doi: 10.1016/S0140-6736(05)67139-5. PubMed DOI

Berends A.M.A., Buitenwerf E., de Krijger R.R., Veeger N., van der Horst-Schrivers A.N.A., Links T.P., Kerstens M.N. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review. Eur. J. Intern. Med. 2018;51:68–73. doi: 10.1016/j.ejim.2018.01.015. PubMed DOI

Zelinka T., Eisenhofer G., Pacak K. Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice. Stress. 2007;10:195–203. PubMed

Zhang H., Faber J.E. Trophic effect of norepinephrine on arterial intima-media and adventitia is augmented by injury and mediated by different alpha1-adrenoceptor subtypes. Circ. Res. 2001;89:815–822. PubMed

Nakaki T., Nakayama M., Yamamoto S., Kato R. Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol. Pharm. 1990;37:30–36. PubMed

Zelinka T., Petrák O., Turková H., Holaj R., Štrauch B., Kršek M., Vrankova A.B., Musil Z., Dušková J., Kubinyi J., et al. High incidence of cardiovascular complications in pheochromocytoma. Horm. Metab. Res. 2012;44:379–384. doi: 10.1055/s-0032-1306294. PubMed DOI

Park J.H., Kim K.S., Sul J.Y., Shin S.K., Kim J.H., Lee J.H., Choi S.W., Jeong J.O., Seong I.W. Prevalence and patterns of left ventricular dysfunction in patients with pheochromocytoma. J. Cardiovasc. Ultrasound. 2011;19:76–82. doi: 10.4250/jcu.2011.19.2.76. PubMed DOI PMC

Majtan B., Zelinka T., Rosa J., Petrák O., Kratka Z., Štrauch B., Tuka V., Vránková A., Michalský D., Novák K., et al. Long-Term Effect of Adrenalectomy on Cardiovascular Remodeling in Patients With Pheochromocytoma. J. Clin. Endocrinol. Metab. 2017;102:1208–1217. doi: 10.1210/jc.2016-2422. PubMed DOI

Kalam K., Otahal P., Marwick T.H. Prognostic implications of global LV dysfunction: A systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart. 2014;100:1673–1680. PubMed

Smiseth O.A., Torp H., Opdahl A., Haugaa K.H., Urheim S. Myocardial strain imaging: How useful is it in clinical decision making? Eur. Heart J. 2016;37:1196–1207. doi: 10.1093/eurheartj/ehv529. PubMed DOI PMC

Sun J.P., Stewart W.J., Yang X.S., Donnell R.O., Leon A.R., Felner J.M., Thomas J.D., Merlino J.D. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am. J. Cardiol. 2009;103:411–415. doi: 10.1016/j.amjcard.2008.09.102. PubMed DOI

Chen Z.W., Huang K.C., Lee J.K., Lin L.C., Chen C.W., Chang Y.Y., Liao C.W., Wu V.C., Hung C.S., Lin Y.H. Aldosterone induces left ventricular subclinical systolic dysfunction: A strain imaging study. J. Hypertens. 2017;36:353–360. PubMed

Plana J.C., Galderisi M., Barac A., Ewer M.S., Ky B., Scherrer-Crosbie M., Ganame J., Sebag I.A., Agler D.A., Badano L.P., et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 2014;27:911–939. PubMed

Park K., Chang S.A., Kim H.K., Park H.E., Na S.H., Kim Y.J., Sohn D.W., Oh B.H., Park Y.B. Normal ranges and physiological changes of midwall fractional shortening in healthy korean population. Korean Circ. J. 2010;40:587–592. PubMed PMC

Krzesinski P., Uzieblo-Zyczkowska B., Gielerak G., Stanczyk A., Kurpaska M., Piotrowicz K. Global longitudinal two-dimensional systolic strain is associated with hemodynamic alterations in arterial hypertension. J. Am. Soc. Hypertens. JASH. 2015;9:680–689. doi: 10.1016/j.jash.2015.06.014. PubMed DOI

Mayet J., Ariff B., Wasan B., Chapman N., Shahi M., Senior R., Foale R.A., Thom S.A. Midwall myocardial shortening in athletic left ventricular hypertrophy. Int. J. Cardiol. 2002;86:233–238. PubMed

Kouzu H., Yuda S., Muranaka A., Doi T., Yamamoto H., Shimoshige S., Hase M., Hashimoto A., Saitoh S., Tsuchihashi K., et al. Left ventricular hypertrophy causes different changes in longitudinal, radial, and circumferential mechanics in patients with hypertension: A two-dimensional speckle tracking study. J. Am. Soc. Echocardiogr. 2011;24:192–199. doi: 10.1016/j.echo.2010.10.020. PubMed DOI

Ishizu T., Seo Y., Kameda Y., Kawamura R., Kimura T., Shimojo N., Xu D., Murakoshi N., Aonuma K. Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease. Hypertension. 2014;63:500–506. PubMed

Galetta F., Franzoni F., Bernini G., Poupak F., Carpi A., Cini G., Tocchini L., Antonelli A., Santoro G. Cardiovascular complications in patients with pheochromocytoma: A mini-review. Biomed. Pharm. 2010;64:505–509. doi: 10.1016/j.biopha.2009.09.014. PubMed DOI

Johnson M.D., Grignolo A., Kuhn C.M., Schanberg S.M. Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats. Life Sci. 1983;33:169–180. PubMed

Ferreira V.M., Marcelino M., Piechnik S.K., Marini C., Karamitsos T.D., Ntusi N.A., Francis J.M., Robson M.D., Arnold J.R., Mihai R., et al. Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction. J. Am. Coll. Cardiol. 2016;67:2364–2374. doi: 10.1016/j.jacc.2016.03.543. PubMed DOI

De Miguel V., Arias A., Paissan A., de Arenaza D.P., Pietrani M., Jurado A., Jaén A., Day P.F. Catecholamine-induced myocarditis in pheochromocytoma. Circulation. 2014;129:1348–1349. doi: 10.1161/CIRCULATIONAHA.113.002762. PubMed DOI

Lyon A.R., Rees P.S., Prasad S., Poole-Wilson P.A., Harding S.E. Stress (Takotsubo) cardiomyopathy—A novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat. Clin. Pract. Cardiovasc. Med. 2008;5:22–29. doi: 10.1038/ncpcardio1066. PubMed DOI

Chiang Y.L., Chen P.C., Lee C.C., Chua S.K. Adrenal pheochromocytoma presenting with Takotsubo-pattern cardiomyopathy and acute heart failure: A case report and literature review. Medicine. 2016;95:e4846. doi: 10.1097/MD.0000000000004846. PubMed DOI PMC

Tafreshi S., Naqvi S.Y., Thomas S. Extra-adrenal pheochromocytoma presenting as inverse takotsubo-pattern cardiomyopathy treated with surgical resection. BMJ Case Rep. 2018;11:e226384. PubMed PMC

Brilakis E.S., Young W.F., Jr., Wilson J.W., Thompson G.B., Munger T.M. Reversible catecholamine-induced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension. J. Heart Lung Transplant. 1999;18:376–380. doi: 10.1016/S1053-2498(98)00014-X. PubMed DOI

Thavendiranathan P., Poulin F., Lim K.D., Plana J.C., Woo A., Marwick T.H. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: A systematic review. J. Am. Coll. Cardiol. 2014;63:2751–2768. PubMed

Turnbull D.M., Johnston D.G., Alberti K.G., Hall R. Hormonal and metabolic studies in a patient with a pheochromocytoma. J. Clin. Endocrinol. Metab. 1980;51:930–933. PubMed

Holland D.J., Marwick T.H., Haluska B.A., Leano R., Hordern M.D., Hare J.L., Fang Z.Y., Prins J.B., Stanton T. Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus. Heart. 2015;101:1061–1066. doi: 10.1136/heartjnl-2014-307391. PubMed DOI

Hoogslag G.E., Abou R., Joyce E., Boden H., Kamperidis V., Regeer M.V., van Rosendael P.J., Schalij M.J., Bax J.J., Marsan N.A., et al. Comparison of Changes in Global Longitudinal Peak Systolic Strain After ST-Segment Elevation Myocardial Infarction in Patients With Versus Without Diabetes Mellitus. Am. J. Cardiol. 2015;116:1334–1339. doi: 10.1016/j.amjcard.2015.07.061. PubMed DOI

Wang T.J., Nam B.H., Wilson P.W., Wolf P.A., Levy D., Polak J.F., D’agostino R.B., O’donnell C.J. Association of C-reactive protein with carotid atherosclerosis in men and women: The Framingham Heart Study. Arterioscler. Thromb. Vasc. Biol. 2002;22:1662–1667. doi: 10.1161/01.ATV.0000034543.78801.69. PubMed DOI

Magyar M.T., Szikszai Z., Balla J., Valikovics A., Kappelmayer J., Imre S., Balla G., Jeney V., Csiba L., Bereczki D. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke J. Cereb. Circ. 2003;34:58–63. doi: 10.1161/01.STR.0000048845.83285.AC. PubMed DOI

Zelinka T., Petrák O., Štrauch B., Holaj R., Kvasnička J., Mazoch J., Pacak K., Widimský J., Jr. Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension. Neuroimmunomodulation. 2007;14:57–64. doi: 10.1159/000107289. PubMed DOI

Sanfilippo F., Corredor C., Fletcher N., Tritapepe L., Lorini F.L., Arcadipane A., Vieillard-Baron A., Cecconi M. Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: A systematic review and meta-analysis. Crit. Care. 2018;22:183. doi: 10.1186/s13054-018-2113-y. PubMed DOI PMC

Mancia G., Fagard R., Narkiewicz K., Redon J., Zanchetti A., Boehm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J. Hypertens. 2013;31:1281–1357. doi: 10.1097/01.hjh.0000431740.32696.cc. PubMed DOI

Force IDFCGT Global Guideline for Type 2 Diabetes: Recommendations for standard, comprehensive, and minimal care. Diabet. Med. 2006;23:579–593. PubMed

Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., Dallongeville J., De Backer G., Ebrahim S., Gjelsvik B., et al. European guidelines on cardiovascular disease prevention in clinical practice: Executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) Eur. Heart J. 2007;28:2375–2414. PubMed

Lenders J.W., Eisenhofer G., Armando I., Keiser H.R., Goldstein D.S., Kopin I.J. Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin. Chem. 1993;39:97–103. PubMed

Lang R.M., Badano L.P., Mor-Avi V., Afilalo J., Armstrong A., Ernande L., Flachskampf F.A., Foster E., Goldstein S.A., Kuznetsova T., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging. 2015;16:233–270. doi: 10.1093/ehjci/jev014. PubMed DOI

Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., Reichek N. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am. J. Cardiol. 1986;57:450–458. PubMed

Mor-Avi V., Lang R.M., Badano L.P., Belohlavek M., Cardim N.M., Derumeaux G., Galderisi M., Marwick T., Nagueh S.F., Sengupta P.P., et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur. J. Echocardiogr. 2011;12:167–205. doi: 10.1093/ejechocard/jer021. PubMed DOI

Farsalinos K.E., Daraban A.M., Unlu S., Thomas J.D., Badano L.P., Voigt J.U. Head-to-Head Comparison of Global Longitudinal Strain Measurements among Nine Different Vendors: The EACVI/ASE Inter-Vendor Comparison Study. J. Am. Soc. Echocardiogr. 2015;28:1171–1181.e2. doi: 10.1016/j.echo.2015.06.011. PubMed DOI

Effect of adrenalectomy on remission of subclinical left ventricular dysfunction in patients with pheochromocytoma: a speckle-tracking echocardiography study